mRNA |
SGC0946 |
GDSC1000 |
pan-cancer |
AAC |
0.093 |
0.008 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.008 |
mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.009 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
0.086 |
0.009 |
mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.01 |
mRNA |
Gemcitabine |
GDSC1000 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.01 |
mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.01 |